documents: FDA-2015-P-2820-0069

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2015-P-2820-0069 FDA FDA-2015-P-2820 Exhibit 20 Lerman, R. FDA halts trial of cancer drug by Seattle's CTI BioPharma after patients die, Source http://www.seattletimes.com/business/fda-halts-cti-biopharma-drug-trial-for-detrimental-effect-on-survival/ February 10, 2016 re: Amendment from Center for Responsible Science Supporting & Related Material Background Material 2016-03-21T04:00:00Z 2016 3     2016-03-21T16:08:23Z   0 0 0900006481ecf1a6

Links from other tables